Diabetes and atherosclerosis

Slides:



Advertisements
Similar presentations
Statins as Protective Agents for Aortic Endothelial Cells Robert Kreisberg West Liberty State College.
Advertisements

Atherosclerosis Mike Clark, M.D.. Terms Arteriosclerosis – hardening of the arteries Atherosclerosis – a form of arteriosclerosis Venosclerosis Arteriolosclerosis.
Pathogenesis of Atherosclerosis Judith Berliner, Ph.D. Departments of Pathology and Medicine Division of Cardiology David Geffen School of Medicine at.
PBL CV 2 Pathophysiology of coronary artery disease.
Low Density Lipoprotein (LDL) LDL derived from VLDL as TAG in VLDL (and IDL) removed by lipoprotein lipase  LDL major cholesterol-carrying lipoprotein.
Faculty Disclosure Amy J. Arouni, MD, FACC Dr. Arouni has listed no financial interest/arrangement that would be considered a conflict of interest.
Journal Reading Myocardial infarction in young people Cardiol J 2009; 16, 4: 307–311 Cardiol J 2008; 15: 21–25 Presented by R 王郁菁 at ER conference.
Aging of the Cardiovascular System (continued)
MCB 135K: Discussion.
ATHEROSCLEROSIS By Joshua Bower Easter Revision 2014
Types of blood vessels: Veins Arteries Common structures Tunica adventitia Tunica media Tunica intima Lumen.
Lesson 1 What is Coronary Artery Disease? Coronary Artery Disease also known as Coronary Heart Disease.
ATHEROSCLEROSIS. Atherosclerosis Atherosclerosis is a disease of large and medium-sized muscular arteries and is characterized by endothelial dysfunction,
Atherosclerosis  hardening of the arteries due to the deposition of atheromas  heart disease is the leading cause of death  caused by the deposition.
Lipoprotein Structures, Function and Metabolism (4)
Atherosclerosis.
03/06/231 K June /06/232 Atherosclerosis Etiology Classic Risk Factors Dyslipidemia Low HDL Epidemiological Studies (e.g. Framingham) Genetic.
Advisor : Assoc. Prof. Dr. Chanvit Leelayuwat. Multi-risk factor of Atherosclerosis  Dyslipidemias - high of low-density lipoprotein cholesterol (LDL-C)
Atherosclerosis: a bioengineer’s perspective
Note Midterm - 4 March in class. Note Signal peptide-A sequence of amino acids that determine whether a protein will be formed on the rough endoplasmic.
ATHEROSCLEROSIS Dr: Wael H.Mansy, MD Assistant Professor
Associate professor of pathology
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 2.
Atherosclerosis CVS lecture 2 Atherosclerosis Shaesta Naseem.
atherosclerosis Jon Yap John A. Burns School of Medicine
Atherosclerosis Atherosclerosis is a specific form of arteriosclerosis (thickening & hardening of arterial walls) affecting primarily the intima of large.
Atherosclerosis CVS lecture 2 Atherosclerosis. Vessel wall structure.
Dr.Hesham Rashid, MD PATHOGENIC MECHANISMS OF ATHEROSCLEROSIS
Cardiovascular Disease
Cardiovascular pathophysiology III
VASCULAR DISEASE Atherosclerosis Jagdish Butany,MBBS,MS,FRCPC, Prof. Dept Lab Med & Pathobiol., Pathologist, UHN-Toronto Gen/Hosp
ATHEROSCLEROSIS PAD,CAROTID STENOSIS, ACUTE LIMB ISCHEMIA Dr.Elham Khoujah Consultant vascular/Endovascular surgeon.
ATHEROSCLEROSIS. Institute of Pathological Physiology Martin Vokurka Winter Semester 2007/08.
순환기질환 - 혈관, 림프관 -.
بسم الله الرحمن الرحيم.
HANDBOOK OF DYSLIPIDEMIA AND ATHEROSCLEROSIS Part One Professor Jean-Charles Fruchart Department of Atherosclerosis (Inserm UR545) Pasteur Institute of.
1 Atherosclerosis ISCHEMIC CHEART DISEASE. 2 Atherosclerosis ATHEROSCLEROSIS IS THE CHRONIC DISEASE WITH THE LIPID AND PROTEIN ABNORMAL METABOLISMS, WITH.
Biochemical Basis of CVD:Part-1 Role of Free radicals & Antioxidants
Lipoprotein Structure, Function, and Metabolism
Atherosclerosis.
Is atherosclerosis a metabolic disease?
Plaque vulnerability Key role of macrophages
Mini Lecture 2 Module: Effects of Tobacco on the Cardiovascular System
ATHEROSCLEROSIS PAD,CAROTID STENOSIS, ACUTE LIMB ISCHEMIA
Cardiovascular Risk and Psoriasis: Beyond the Traditional Risk Factors
Coronary disease million Cancer Cerebrovascular disease
Volume 17, Issue 6, Pages (June 2013)
Section 3: Role of lipids in endothelial function
Focus: Lipids and the endothelium
B. Mechanisms of disease
Section I: RAS manipulation
Arteriosclerosis & Atherosclerosis
Advanced Nutrition Diet and Cardiovascular Disease 1
CLA-1/SR-BI protein may promote cholesterol removal from peripheral cells Figure 84 The CLA-1 receptor is the human homolog of the SR-I receptor in mice.
Figure 1 Innate immune responses in atherosclerosis
HDL and Atherosclerosis
Nat. Rev. Cardiol. doi: /nrcardio
Arterial wall: structure and function
Lipid core constitution Activated macrophages accumulate lipids
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?  Mustafa Arici, John Walls  Kidney International 
Oxidative stress, AGE, and atherosclerosis
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Monocyte-Macrophages and T Cells in Atherosclerosis
Atherosclerosis Dr:HAMED ALGHAMDI.
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?  Mustafa Arici, John Walls  Kidney International 
Macrophages in the Pathogenesis of Atherosclerosis
How to reduce the risk of plaque rupture
Impaired Lung Function and Risk for Stroke
Atherosclerosis  Christopher K. Glass, Joseph L. Witztum  Cell 
NF-κB, Inflammation, and Metabolic Disease
Presentation transcript:

Diabetes and atherosclerosis Figure 26 Chronic hyperglycemia leads to accumulation of glycated proteins in the blood. This causes an increase in vascular permeability which, in turn, increases the level of oxidized LDL. There is also a release of cytokines, which increases the level of vascular inflammation.

Tobacco and atherosclerosis Figure 27 Smoking increases the formation of oxidative free radicals, which raises the level of oxidized LDL. Nicotine has several direct effects, which include: increased cytokine production (which raises the level of vascular inflammation); direct cytotoxicity; vasospasm.

Dyslipidemia and atherosclerosis Figure 28 Atherogenic lipoproteins (e.g. LDL, apo B-rich particles like Lp-B:C-III) penetrate the arterial wall and induce: expression of adhesion molecules (which capture monocytes which then migrate into the intima); differentiation of macrophages (which release inflammatory cytokines); increased lipoprotein capture and penetration.

HTN, hemodynamic factor and atheroclerosis Figure 29 Hypertension creates areas of low shear stress within arteries, which in turn results in: increased endothelial permeability; increased duration of lipoprotein contact with the endothelium; increased lipoprotein penetration; decreased endothelium-dependent vasodilation.

How to reduce plaque formation Intervention on risk factors Figure 30 Risk factor modification is a key therapeutic target in patients with and without clinically manifested atherosclerotic disease.